本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Taro Pharmaceutical Industries L

42.97
+0.0000
成交量:- -
成交额:- -
市值:16.15亿
市盈率:29.98
高:42.97
开:42.97
低:42.97
收:42.97
数据加载中...
2024/06/24

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/06/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/24

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/05/23

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/05/14

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/05/08

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/04/15

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/03/21

SEC问询函

Form CORRESP - Correspondence
2024/03/20

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/03/11

SEC问询函

Form CORRESP - Correspondence
2024/03/11

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2024/02/15

私有化交易

Form SC 13E3 - Going private transaction by certain issuers
2024/01/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]